Biontech publishes first sustainability report and receives “prime” rating by iss esg

Mainz, germany, may 21, 2021 –  biontech se (nasdaq: bntx, “biontech” or “the company”), a next generation immunotherapy company pioneering novel therapies for cancer and infectious diseases, has published its first sustainability report . the report focuses on the company's commitment to making an impact on good health and well-being, anchoring responsibility in its core business, ensuring biontech's resilience through responsible governance, creating values and shaping a sustainable corporate culture for growth. biontech was awarded a "prime" rating in its first esg rating by the rating agency iss esg. biontech is now ranked by iss esg in the top 10% of all rated companies in the pharmaceuticals and biotechnology sector.
BNTX Ratings Summary
BNTX Quant Ranking